US nutraceutical company Bonne Santé Group has launched Bonne Santé Natural Immunology, a new range of nutraceutical products designed to boost the immune system functions. Bonne Santé Natural Immunology is made up of three separate products that use proprietary formulas created by Jorge Lamazares, the chief formulator of the company. Included in the Bonne Santé […]
Continue reading …Remdesivir EUA status : The US has officially pushed the use of remdesivir for treating the novel coronavirus with the Food and Drug Administration (FDA) granting emergency use authorization (EUA) to the investigational COVID-19 drug candidate being developed by Gilead Sciences. The EUA lets the antiviral drug candidate to be used for the treatment of […]
Continue reading …Eiger BioPharmaceuticals said that it has dosed the first patients in a phase 2 trial of its hepatitis delta virus drug candidate peginterferon lambda (Lambda) in outpatients at the Stanford University School of Medicine having mild COVID-19. The California-based biopharma company said that nearly 120 patients will be randomly grouped in a 1:1 ratio to […]
Continue reading …US biotech company CytoAgents has joined forces with CDMO and CRO services provider Quotient Sciences to accelerate the development of its COVID-19 drug candidate GP1681 into human clinical trials for the treatment of cytokine storm. According to the partners, scientific consensus is building that severe illness resulting from COVID-19 and other infectious diseases is triggered by […]
Continue reading …Citius Pharmaceuticals has made a Pre-IND submission to the US Food and Drug Administration for a novel stem cell therapy for acute respiratory distress syndrome (ARDS) in COVID-19 patients. In this regard, the late-stage specialty pharma company submitted a pre-IND meeting request and supporting briefing documents to the FDA’s Center for Biologics Evaluation and Research […]
Continue reading …Shanghai Fosun Pharmaceutical (Fosun Pharma) has been granted the emergency use authorization (EUA) status for its COVID-19 RT-PCR detection kit from the US Food and Drug Administration (FDA). Fosun Long March, a fully-owned subsidiary of Fosun Pharma, developed the COVID-19 RT-PCR detection kit which already has a medical device registration certificate from the China National Medical […]
Continue reading …Researchers at the University of Oxford in the UK have commenced the ChAdOx1 nCoV-19 vaccine trial in healthy human volunteers to test the vaccine candidate’s ability in protecting against the novel coronavirus. Nearly 1,100 people, aged between 18 and 55 are taking part in the Oxford University coronavirus vaccine trial, of which half of them […]
Continue reading …DNA-based COVID-19 vaccine candidate : Researchers at the University of Waterloo in Canada are developing a DNA-based vaccine candidate which can be given via nasal route to protect from novel coronavirus. The vaccine will be formulated to work on tissues in the nasal cavity and lower respiratory tract which will enable it to replicate within […]
Continue reading …French pharma company Sanofi has announced a COVID-19 vaccine partnership with GlaxoSmithKline (GSK) to develop an adjuvanted vaccine for the novel coranavirus, by combining their drug discovery technologies. Sanofi will provide its S-protein Covid-19 antigen based on recombinant DNA technology to the partnership. The technology is said to be used for generating an exact genetic […]
Continue reading …